Usona Institute Beginning Phase 2 Clinical Trials Using Psilocybin to Treat Major Depressive Disorder
Enrollment of study volunteers is expected to start within the next two months.
Enrollment of study volunteers is expected to start within the next two months.
The center is the first of its kind in the US and will propel psychedelic research to a new level.
Anorexia has phenomenological parallels to anxiety and addiction, both of which have been shown to improve with psilocybin-assisted interventions.
The evidence points to several possibilities. It could be psilocybin or a combination of factors.
More and more women are self-treating with psychedelics to relieve their symptoms.
The serotonin 5-HT2C receptor may play a key role.
In spite of the hype, a new Imperial College study says the jury is still out.
There’s nausea, paralysis, and fatigue to name a few.
This study provides more evidence for the entourage effect in magic mushrooms.
A look into the potential therapeutic application of psychedelics in disorders of consciousness.
Psychedelic Science Review is working to bring cutting-edge science in the field of psychedelics to the public in the most accessible, thorough and accurate way possible. Join our communities on Facebook, Twitter, LinkedIn and Instagram and share our content with your network to help us bring scientifically-backed information about psychedelics to the world.
NEW! Shop the PSR Supporter Store to show your support for psychedelic science.